Clinical Trial Update: A Multicenter Real-World Study on TKI Therapy After Progression on First-Line TKI/IO Therapy or TKI/IO Therapy After Progression on First-Line TKI in Chinese Patients With Metastatic Renal Cell Carcinoma (mRCC)

View source ↗

Summary

Clinical trial assessing second-line TKI therapy in Chinese patients with metastatic renal cell carcinoma after progression on first-line TKI/IO therapy or afte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: RCC | Status: NOT_YET_RECRUITING